Nadler Financial Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$487K Buy
1,385
+4
+0.3% +$1.43K 0.05% 79
2025
Q4
$452K Sell
1,381
-103
-7% -$32.7K 0.04% 85
2025
Q3
$419K Sell
1,484
-49
-3% -$14.2K 0.04% 93
2025
Q2
$428K Buy
1,533
+61
+4% +$17.3K 0.04% 83
2025
Q1
$459K Buy
1,472
+5
+0.3% +$1.48K 0.05% 76
2024
Q4
$382K Buy
1,467
+6
+0.4% +$1.78K 0.04% 84
2024
Q3
$471K Buy
1,461
+5
+0.3% +$1.64K 0.05% 72
2024
Q2
$455K Buy
1,456
+5
+0.3% +$1.47K 0.05% 70
2024
Q1
$413K Buy
1,451
+5
+0.3% +$1.46K 0.05% 71
2023
Q4
$416K Buy
1,446
+6
+0.4% +$1.64K 0.06% 68
2023
Q3
$387K Buy
1,440
+6
+0.4% +$1.5K 0.06% 68
2023
Q2
$318K Buy
1,434
+7
+0.5% +$1.62K 0.05% 78
2023
Q1
$345K Buy
1,427
+7
+0.5% +$1.72K 0.05% 75
2022
Q4
$373K Buy
1,420
+5
+0.4% +$1.34K 0.07% 72
2022
Q3
$319K Sell
1,415
-2
-0.1% -$485 0.06% 77
2022
Q2
$345K Buy
1,417
+11
+0.8% +$2.7K 0.06% 76
2022
Q1
$340K Sell
1,406
-67
-5% -$15.4K 0.05% 82
2021
Q4
$331K Buy
1,473
+6
+0.4% +$1.27K 0.05% 89
2021
Q3
$312K Buy
1,467
+6
+0.4% +$1.38K 0.05% 88
2021
Q2
$356K Buy
1,461
+5
+0.3% +$1.23K 0.06% 80
2021
Q1
$362K Buy
1,456
+5
+0.3% +$1.19K 0.06% 75
2020
Q4
$334K Buy
1,451
+5
+0.3% +$1.15K 0.06% 78
2020
Q3
$368K Buy
1,446
+4
+0.3% +$991 0.08% 72
2020
Q2
$340K Buy
1,442
+5
+0.3% +$1.14K 0.09% 65
2020
Q1
$291K Buy
1,437
+5
+0.3% +$1.09K 0.09% 64
2019
Q4
$345K Buy
1,432
+4
+0.3% +$882 0.09% 66
2019
Q3
$276K Sell
1,428
-494
-26% -$94.8K 0.08% 67
2019
Q2
$354K Buy
1,922
+148
+8% +$26.5K 0.1% 61
2019
Q1
$337K Buy
1,774
+8
+0.5% +$1.53K 0.11% 59
2018
Q4
$344K Buy
1,766
+7
+0.4% +$1.37K 0.11% 57
2018
Q3
$365K Buy
1,759
+7
+0.4% +$1.38K 0.1% 58
2018
Q2
$323K Buy
1,752
+222
+15% +$39.3K 0.09% 62
2018
Q1
$261K Sell
1,530
-68
-4% -$12.5K 0.08% 67
2017
Q4
$278K Buy
1,598
+6
+0.4% +$1.06K 0.08% 69
2017
Q3
$297K Buy
1,592
+6
+0.4% +$1.06K 0.1% 66
2017
Q2
$273K Sell
1,586
-130
-8% -$21.1K 0.09% 65
2017
Q1
$282K Sell
1,716
-465
-21% -$77.3K 0.1% 66
2016
Q4
$319K Buy
2,181
+89
+4% +$13.4K 0.12% 63
2016
Q3
$349K Sell
2,092
-19
-0.9% -$3.21K 0.14% 58
2016
Q2
$321K Buy
2,111
+6
+0.3% +$933 0.14% 58
2016
Q1
$316K Buy
2,105
+6
+0.3% +$891 0.14% 59
2015
Q4
$341K Sell
2,099
-26
-1% -$4.09K 0.15% 56
2015
Q3
$294K Sell
2,125
-49
-2% -$7.72K 0.15% 59
2015
Q2
$334K Buy
2,174
+115
+6% +$18.4K 0.16% 57
2015
Q1
$329K Buy
2,059
+5
+0.2% +$787 0.16% 57
2014
Q4
$327K Buy
2,054
+181
+10% +$28.2K 0.17% 54
2014
Q3
$263K Buy
1,873
+172
+10% +$22.5K 0.16% 58
2014
Q2
$201K Buy
1,701
+4
+0.2% +$463 0.13% 68
2014
Q1
$209K Buy
+1,697
New +$206K 0.14% 64
2013
Q3
Sell
-2,524
Closed -$249K 74
2013
Q2
$249K Buy
+2,524
New +$262K 0.18% 71

Other funds holding AMGN

Nadler Financial Group's AMGN Position: Q1 2026 in Review

Nadler Financial Group increased its Amgen (AMGN) stake by 0.29% in Q1 2026, buying an estimated $1.43K and bringing the position to 1,385 shares worth $487K. The position accounts for 0.05% of the portfolio, ranked #79.

Nadler Financial Group first reported a position in AMGN in Q2 2013 and has held it in 50 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Nadler Financial Group held 1,385 shares of Amgen worth $487K as of Q1 2026.
  • Nadler Financial Group bought 4 Amgen shares in Q1 2026, an estimated $1.43K.
  • Amgen made up 0.05% of Nadler Financial Group's portfolio in Q1 2026, its #79 holding.
  • Nadler Financial Group first reported a position in Amgen in Q2 2013 and has held it in 50 quarters since.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Nadler Financial Group's 13F filing for Q1 2026, filed 4 May 2026.